Palladone

Hydromorphone hydrochloride extended release.

Topic mentions per year

Topic mentions per year

2005-2013
012320052013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
The sensitivity of controlled release dosage forms to the presence of ethanol in the gastro intestinal tract is critical, if the… (More)
Is this relevant?
2010
2010
In 2005, Palladone, an extended-release capsule, was withdrawn from the market after clinical testing showed subjects who took… (More)
Is this relevant?
Review
2010
Review
2010
  • David S Craig
  • P & T : a peer-reviewed journal for formulary…
  • 2010
approved in the U.S., and they remain the primary alternatives to oxymorphone ER today. Some pain specialists do not consider LA… (More)
  • table 1
Is this relevant?
Review
2009
Review
2009
Hydromorphone is a semi-synthetic μ-agonist commercially available in oral, rectal and injectable formulations for the control of… (More)
Is this relevant?
2008
2008
UNLABELLED The recent withdrawal of hydromorphone hydrochloride extended-release capsules (Palladone; Purdue Pharma L.P… (More)
Is this relevant?
2005
2005
  • The Medical letter on drugs and therapeutics
  • 2005
Palladone is a new long-acting formulation of the opioid agonist hydromorphone that is taken once daily for treatment of chronic… (More)
Is this relevant?
Review
2005
Review
2005
Hydromorphone, one of the oldest and most potent of opioids, is an effective alternative to morphine. With a variety of routes of… (More)
Is this relevant?
2005
2005
  • FDA consumer
  • 2005
 
Is this relevant?